Overall rank by patents
#444
Across all tracked assignees
USPTO PatentsView assignee record - 1,025 granted patents across 130 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
DEKA holds 1,025 US patents across 130 technology areas, rank #444 of 50,000 tracked assignees.
DEKA Products Limited Parternship has been granted 1,025 US utility patents between 2015 and 2025, placing DEKA Products Limited Parternship at rank #444 across all assignees tracked by PlainPatent. This portfolio spans 130 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.4 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, DEKA Products Limited Parternship is one of the broader-portfolio assignees in the PatentsView dataset. By volume, DEKA sits between Contemporary Amperex Technology Co., Limited (1,029 patents, rank #440) and Mayo Foundation For Medical Education And Research (1,020 patents, rank #448) - the closest US assignees by grant volume. The composite Innovation Score of 65.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 563 grants, compared with 462 in the 2015–2019 window, a +22% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. DEKA Products Limited Parternship's 15.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark DEKA Products Limited Parternship against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED
1,029 patents
Carl Zeiss SMT GmbH
1,028 patents
DSM IP ASSETS B.V.
1,027 patents
APTIV TECHNOLOGIES AG
1,025 patents
Palo Alto Research Center Incorporated
1,025 patents
DEKA Products Limited Parternship
1,025 patents
KOBE STEEL LTD.
1,023 patents
Commvault Systems, Inc.
1,020 patents
Mayo Foundation for Medical Education and Research
1,020 patents
What this shows DEKA holds 1,025 patents at rank #444, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #444 in granted patent volume.
Other assignees with the most granted patents in DEKA's primary technology class.
DEKA's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
65 Top 1% higher than 99% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 65 | 6.3% |
| 2016 | 95 | 9.3% |
| 2017 | 101 | 9.9% |
| 2018 | 97 | 9.5% |
| 2019 | 104 | 10.1% |
| 2020 | 102 | 10.0% |
| 2021 | 83 | 8.1% |
| 2022 | 93 | 9.1% |
| 2023 | 115 | 11.2% |
| 2024 | 98 | 9.6% |
| 2025 | 72 | 7.0% |
Top 15 of 130 technology areas
Overall rank by patents
#444
Across all tracked assignees
65.3 out of 100
How to use this portfolio
DEKA's 1,025 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.